This inventor holds 5 USPTO granted patents. Top assignee: Exela Holdings, Inc.. Active years: 2018-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2024
Title: Sreerarama Murthy Mallipeddi: Innovator in Phytonadione Compositions
Introduction
Sreerarama Murthy Mallipeddi is a notable inventor based in Lenoir, NC (US). He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on phytonadione. With a total of 5 patents to his name, Mallipeddi continues to push the boundaries of innovation in his area of expertise.
Latest Patents
Mallipeddi's latest patents include advancements in stable phytonadione compositions for parenteral administration. These compositions comprise the (E) isomer of phytonadione at or greater than 97% w/w as the active ingredient, while being substantially free of the (Z) isomer. The compositions are designed to be stable, sterile, and particulate-free. Furthermore, they aim to reduce or avoid allergic reactions to benzyl alcohol and polysorbate. In some aspects, these compositions are free or substantially free of benzyl alcohol and/or contain reduced amounts of polysorbate. Methods of manufacture and administration are also provided in his patents.
Career Highlights
Sreerarama Murthy Mallipeddi is currently associated with Exela Holdings, Inc. His work has been instrumental in developing innovative solutions that enhance the safety and efficacy of pharmaceutical products. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Mallipeddi has collaborated with notable colleagues such as Phanesh B Koneru and Jonathan E Sterling. These collaborations have further enriched his research and contributed to the advancement of his patented technologies.
Conclusion
Sreerarama Murthy Mallipeddi is a distinguished inventor whose work in phytonadione compositions has made a significant impact in the pharmaceutical industry. His innovative approaches continue to pave the way for safer and more effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile